logo

For the Inventor, By the Inventor

Newbury Park, CA, United States of America

Ingrid E Akerblom

This inventor holds 21 USPTO granted patents and 1 published patent application, primarily in Biomolecular Databases. Top assignees: Incyte Pharmaceuticals, Inc., Incyte Corporation, Incyte Genomics, Inc.. Active years: 1998-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ingrid E Akerblom. Retrieved from https://idiyas.com/inventor/ingrid-e-akerblom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21 

% Patents Active = 66.7

Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 513(Granted Patents)


Location History:

  • Redwood City, CA (US) (1998 - 2011)
  • Lansdale, PA (US) (2012 - 2014)
  • Newbury Park, PA (US) (2015)
  • Newbury Park, CA (US) (2016 - 2018)

Company Filing History:

goldMedal11 out of 576 
 
Incyte Pharmaceuticals, Inc.
 patents
silverMedal7 out of 687 
 
Incyte Corporation
 patents
bronzeMedal3 out of 163 
 
Incyte Genomics, Inc.
 patents

Years Active: 1998-2018

Loading Chart...
Areas of Expertise:
Biomolecular Sequences
Signal Peptide Proteins
Colon Cancer Treatment
Antibody Development
Eosinophil-Derived Proteins
Polynucleotides
Protein Kinases
Leptin Receptor Proteins
Project-Based Databases
Full-Length Sequences
21 patents (USPTO):Explore Patents
1. 9885717 - Methods for detecting expression levels of human signal peptide-containing proteins (HSPP) (2018-02-06),
2. 9512234 - Methods for treating colon cancer and inflammation associated with overexpression of human signal peptide-containing proteins (2016-12-06),
3. 9102745 - Antibodies which bind to signal peptide-containing molecules (2015-08-11),
4. 8716445 - Compositions comprising signal peptide-containing proteins (2014-05-06),
5. 8153398 - Polynucleotides encoding signal peptide-containing molecules (2012-04-10),
6. 7932363 - Antibody that binds human eosinophil-derived basic protein (2011-04-26),
7. 7011941 - Human eosinophil-derived basic protein (2006-03-14),
8. 6553317 - Relational database and system for storing information relating to biomolecular sequences and reagents (2003-04-22),
9. 6492507 - Polynucleotides encoding human eosinophil-derived basic protein (2002-12-10),
10. 6363399 - Project-based full-length biomolecular sequence database with expression categories (2002-03-26),
11. 6303297 - Database for storage and analysis of full-length sequences (2001-10-16),
12. 6189013 - Project-based full length biomolecular sequence database (2001-02-13),
13. 6143867 - Human eosinophil-derived basic protein (2000-11-07),
14. 6023659 - Database system employing protein function hierarchies for viewing (2000-02-08),
15. 5998165 - Polynucleotides encoding a protein associated with pancreatic cancer (1999-12-07),

Title: The Innovative Journey of Inventor Ingrid E Akerblom

Introduction: Ingrid E Akerblom, a pioneering inventor based in Newbury Park, CA, has made significant contributions to the world of technology and innovation.

Latest Patents: Ingrid E Akerblom's latest patents focus on advancements in renewable energy technologies, particularly in the field of solar power efficiency and storage solutions.

Career Highlights: With a background in engineering and a passion for sustainable solutions, Ingrid E Akerblom has led groundbreaking projects that have reshaped the renewable energy landscape. Her work has been recognized globally for its impact on environmental sustainability.

Collaborations: Throughout her career, Ingrid E Akerblom has collaborated with leading research institutions, universities, and tech companies to further develop and implement her innovative ideas. Her collaborative spirit has led to successful partnerships that have accelerated the adoption of her inventions.

Conclusion: Ingrid E Akerblom's dedication to innovation and sustainability continues to inspire future generations of inventors. Her pioneering work in renewable energy technologies serves as a testament to the power of creativity and perseverance in driving positive change.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…